Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extreme laser pulse-energy measurements by means of photon momentum.
Williams PA, Rogers KA, Divoky M, Porrovecchio G, Tesař J, Smid M, Lehman JH. Williams PA, et al. Among authors: rogers ka. Opt Express. 2022 Feb 28;30(5):7383-7393. doi: 10.1364/OE.448815. Opt Express. 2022. PMID: 35299502 Free article.
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA. Kittai AS, et al. Among authors: rogers ka. J Clin Oncol. 2024 Mar 29:JCO2400033. doi: 10.1200/JCO.24.00033. Online ahead of print. J Clin Oncol. 2024. PMID: 38552193
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
Hampel PJ, Swaminathan M, Rogers KA, Parry EM, Burger JA, Davids MS, Ding W, Ferrajoli A, Hyak JM, Jain N, Kenderian SS, Wang Y, Wierda WG, Woyach JA, Parikh SA, Thompson PA. Hampel PJ, et al. Among authors: rogers ka. Blood Adv. 2024 Mar 27:bloodadvances.2023012080. doi: 10.1182/bloodadvances.2023012080. Online ahead of print. Blood Adv. 2024. PMID: 38537065
Pairing obinutuzumab with venetoclax in relapsed CLL.
Rogers KA, Thompson PA. Rogers KA, et al. Leuk Lymphoma. 2024 May;65(5):543-545. doi: 10.1080/10428194.2024.2323682. Epub 2024 Mar 18. Leuk Lymphoma. 2024. PMID: 38497550 No abstract available.
216 results